The Institute of Public Health (ISP) set off the alarms after detecting the marketing of three drugs without health authorization in the country. According to the agency, these products do not have support to guarantee their safety, effectiveness or quality, which represents a direct danger to the health of those who consume them. In addition, they were detected with irregular packaging and without information about their origin or expiration date, a situation that aggravates the lack of health control.
The drugs indicated by the ISP are the following:
- CLEN-40 (Clenbuterol Hydrochloride)
- DIURET-40 (Extra Strong Diuretic)
- TRIAC-40 (Tricana Tiratriacol or TA3)
The three products are presented with alleged Argentine origin and falsified logos of the Association of Medical Propaganda Agents. However, the ISP clarified that its manufacturing and distribution are not officially registered. The drugs They are sold on social networks and informal stores, which makes it impossible to verify their real composition and increases the risk of adverse effects.
Source: Shutterstock.
The first of the drugs is Clen-40, it contains clenbuterol, a substance with anabolic effects used in the veterinary field and prohibited in people due to its impact on the heart. It can cause tachycardia, arrhythmias and elevated blood pressure. Meanwhile, Diuret-40 mixes caffeine, pyridoxine and plant extracts, causing potassium loss, dehydration and hypotension. Finally, Triac-40, which affects thyroid hormones, is banned because of the high risk it represents compared to its potential therapeutic benefits.
The ISP warned that these drugs They lack a batch number, manufacturing date, and expiration date, making it impossible to trace their origin or confirm their actual contents. This lack of traceability implies a serious health risk, since it cannot be ensured that the ingredients are as declared.
